Lec 15 - Drug Dev Flashcards
what is the dif between pharma and biotech
pharma is drugs from chemicals, biotech is tech based on bio
describe the cycle from drug discovery to evolution of product. where does preclin studied, clinical trial review, submission review, monitoring and intervention, and product removal occur?
drug discovered
pre clin studises not in humans
then health canada approves studying in humans
clinical trials
clinical trial review
drug submission
submission review
licence
post market
knowledge aquisition
monitoring, needed interventions
revaluation
removal if needed
evolution
what are the four phases of drug discovery? what happens in each?
target discovery: finding the targets for the drug
target validation: eliminating the wrong targets
lead generation and refinement: generating molecules
preclinical development: eliminating and dvancing molecules
this all happens in drug discovery! way before any trials and testing!
t/f: all of the drugs make it to the market. why or why not?
false: lots of the drugs get eliminated along the way bc they done pass tests
describe the drug dev funnel
lots during basic research, funneling out from 100 000-25000 to 10-20 in preclin/animal studies
then 5-10 in phase 1
2-5 in phase 2
2 in phase 3
1 in phase 4
typically how long does the drug dev process take? describe what happens at each time point
in total up to 15 years.
3-6 years spend on drug discovery and preclin
6-7 years spent on clinical studies
0.5-2 years spent on regulatory review
afterwards is post marketing review
contrast phase 1, 2, 3, clinical studies
- looking mainly at pk/pd, dosing range, safety
- looking at efficacy, dose, safety
- looking at safety, efficiacy
more volunteers in each category as u go up the phases
why was the covid vaccine timeline so accelerated?
many people working on it at once, review process happened a lot faster
what happens after you determine a vaccines efficacy?
approval, manufacturing, global vaccinations, and future directions
what does the second wave of vaccines do?
improves protection, deals with mutants
what is the drug dev process in the US?
drug discovery, preclinical studies + IND application
clinical development, fda review, post market monitoring
how does canada regulate food and therapeutics (ie: legislation? regulation?)`
food and drug act legislation, and food and drug regulation, and natural health product regulation
what is the role of the health products and food branch?
monitors safety and efficacy of health product, food, and vet drugs
nutrition and food policies
public health response wrt food and nutrition
what is the pharmaceutical drugs directorate> what do they do?
they review safety and efficacy of prescription drugs, clinical trial applications,
what does the patent act state?
manufacturers of a brand name drug have 17 years of patent protection from patent issuing or 20 years from patent filing date
when should preclinical testing happen? what do you examine during this phase?
before clinical trial application for humans. look at structure activity relationship, animal studies, pk, adrs, pregnancy
when does the clinical trial application occur>
after preclin testing and before clinical trials start
describe pathway from drug synthesis to new drug submission
synthestis, preclin testing, cta, clincal traisl (1, 2,3), new drug submission
what happens during phase 1 of clinical trials? what are u measuring? how many people?
drug is admin to health volunteers - small group – with controlled inclusion and exclusion.
measuring pk parameters, some safety by data safety monitoring board.
contrast blinding and double blinding
blinding: patient doesnt know what theyre getting
double bl: patient and doc dont know what theyre getting
when would you not use healthy volunteers for phase 1?
for wnticancer drugs, hiv drugs: you wouldnt want to test on health patients bc these are very potent drugs.
what is the inclusion/exclusion criteria for phase 1?
want people that are going to stay for the whole study and who will have the least adverse effects
what is the main goal of phase 1 clinical trial?
to figure out the pk principles of a drug
when would you bypass phase 1 clinical trial?
when youre patient population is very sick and the drug is such that it would be harmful to a healthy patient
why shouldnt you give all patients the dose at the same time during a clinical trial?
wait some time so you can see if the drug is affecting someone first (2006 paraxel for tgn1412 - leukemia and arthritis drug, 2016 trial in france)
what happens during a phase 2 clinical trial? what is the main goal?
actually testing the drugs in patients, seeing if the drug has therapeutic use, dosing adjustments, and examining safety
what is proof of concept?
seeing if a drug does what it is supposed to from a therapeutic perspective
what happens during phase 3 clinical trial?
thousands of patients, comparisons to stand therapy, controlled inc.ex, expesnsive, can be sep while waiting for notice of compliance